Skip to main content

Animations

MJFF Publications

1551 - 1560 of 6324 Results
Title
Year
  • Year
  • 2017
  • 2018
  • 2017
  • 2010
  • 2006
  • 2008
  • 2015
  • 2009
  • 2009
  • 2016
  • Summary Details
    OPEN
    Title: Domain‐specific cognitive impairment in non‐demented Parkinson's disease psychosis
    Journal Name: International Journal of Geriatric Psychiatry
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/gps.4736
    Citation Count: 10
  • Summary Details
    OPEN
    Title: ELISA method to detect α-synuclein oligomers in cell and animal models
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0196056
    Citation Count: 67
  • Summary Details
    OPEN
    Title: Parkinson disease–associatedLRRK2 G2019Stransgene disrupts marrow myelopoiesis and peripheral Th17 response
    Journal Name: Journal of Leukocyte Biology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1189/jlb.1a0417-147rr
    Citation Count: 30
  • Summary Details
    OPEN
    Title: CD3 in Lewy pathology: does the abnormal recall of neurodevelopmental processes underlie Parkinson’s disease
    Journal Name: Journal of Neural Transmission
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00702-010-0485-5
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Slow progressive degeneration of nigral dopaminergic neurons in postnatal Engrailed mutant mice
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.0602116103
    Citation Count: 137
  • Summary Details
    OPEN
    Title: Enantiomeric Propanolamines as selectiveN-Methyl-d-aspartate 2B Receptor Antagonists
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/jm8002153
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Reproducibility of a Parkinsonism-related metabolic brain network in non-human primates: A descriptive pilot study with FDG PET
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26302
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Synthesis and SAR of a novel positive allosteric modulator (PAM) of the metabotropic glutamate receptor 4 (mGluR4)
    Journal Name: Bioorganic & Medicinal Chemistry Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bmcl.2009.07.072
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer’s disease
    Journal Name: Biomarkers
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3109/13547500903108423
    Citation Count: 108
  • Summary Details
    OPEN
    Title: α‐synuclein conformational antibodies fused to penetratin are effective in models of Lewy body disease
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.321
    Citation Count: 39
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.